Author:
Miner Jeffrey N.,Tan Philip K.,Hyndman David,Liu Sha,Iverson Cory,Nanavati Payal,Hagerty David T.,Manhard Kimberly,Shen Zancong,Girardet Jean-Luc,Yeh Li-Tain,Terkeltaub Robert,Quart Barry
Funder
Ardea Biosciences, Inc., San Diego, CA, a wholly owned subsidiary of AstraZeneca PLC
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Neogi T. Clinical practice: gout. N Engl J Med. 2011;364(5):443–52.
2. Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.
3. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008;58(1):26–35.
4. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31(8):1582–7.
5. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011;63(10):3136–41.
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献